[HTML][HTML] The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis

C Lampl, A MaassenVanDenBrink… - The journal of headache …, 2023 - Springer
Objective While there are several trials that support the efficacy of various drugs for migraine
prophylaxis against placebo, there is limited evidence addressing the comparative safety …

Current status of antiepileptic drugs as preventive migraine therapy

SK Parikh, SD Silberstein - Current treatment options in neurology, 2019 - Springer
Abstract Background Antiepileptic drugs (AEDs) are an important class of agents used in the
treatment of migraine, a neurological disorder that imparts significant socioeconomic …

Preventive treatment for episodic migraine

SK Parikh, SD Silberstein - Neurologic clinics, 2019 - neurologic.theclinics.com
Migraine is a disabling central nervous system disorder characterized by moderate or
severe head pain. Migraine is prevalent; it is the third most common disorder in the world. 1 …

[HTML][HTML] Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era

E Rollo, M Romozzi, C Vollono… - Current …, 2023 - ncbi.nlm.nih.gov
Migraine and epilepsy are fundamentally distinct disorders that can frequently coexist in the
same patient. These two conditions significantly differ in diagnosis and therapy but share …

[HTML][HTML] Chronic pregabalin treatment protects against spreading depolarization and alters hippocampal synaptic characteristics in a model of familial hemiplegic …

SM Cain, SRA Alles, R Gopaul, LP Bernier, AC Yung… - Molecular Brain, 2023 - Springer
Familial hemiplegic migraine type-1 (FHM-1) is a form of migraine with aura caused by
mutations in the P/Q-type (Cav2. 1) voltage-gated calcium channel. Pregabalin, used …

Preventive treatment of migraine: Non-specific oral agents

E Tronvik, S Giri, W Young - Handbook of Clinical Neurology, 2024 - Elsevier
Migraine headache is highly prevalent and the most common neurologic disorder, affecting
one billion people worldwide. It is also the most disabling condition in people under 50, with …

Pharmacological options for the treatment of chronic migraine pain

I Urits, K Gress, K Charipova, AM Zamarripa… - Best Practice & …, 2020 - Elsevier
Migraine is a debilitating neurological condition with symptoms typically consisting of
unilateral and pulsating headache, sensitivity to sensory stimuli, nausea, and vomiting. The …

[HTML][HTML] Consensus of the Brazilian Headache Society (SBCe) for the prophylactic treatment of episodic migraine: Part I

EM Melhado, PSF Santos, AO Kaup… - Arquivos de Neuro …, 2022 - SciELO Brasil
Abstract The Brazilian Headache Society (Sociedade Brasileira de Cefaleia, SBCe, in
Portuguese) nominated a Committee of Authors with the aim of establishing a consensus …

Противоэпилептические препараты в лечении мигрени и невропатической боли

НД Сорокина, СС Перцов, ГВ Селицкий… - Российский журнал …, 2021 - elibrary.ru
В терапии как невропатической боли, так и мигренозной головной боли в настоящее
время наряду с различными по механизмам действия фармакологическими …

[HTML][HTML] Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study

E Nasiri, A Naseri, M Talebi - Iranian Journal of Child Neurology, 2023 - ncbi.nlm.nih.gov
Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan,
Iran; A Population-based Study - PMC Back to Top Skip to main content NIH NLM Logo …